欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Tyrosine Kinase-VEGFR-EVT801
EVT801

Chemical Structure : EVT801

CAS No.: 1412453-70-3

EVT801 (EVT-801, EVT 801)

货号: PC-20338Not For Human Use, Lab Use Only.

EVT801 (EVT 801) is a potent, selective VEGFR-3 inhibitor with biochemical IC50 of 11 nM, inhibits cellular VEGFR-3 autophosphorylation with IC50 of 39 nM.

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

    生物&药学活性

    EVT801 (EVT 801) is a potent, selective VEGFR-3 inhibitor with biochemical IC50 of 11 nM, inhibits cellular VEGFR-3 autophosphorylation with IC50 of 39 nM.
    EVT801 displays 30-fold and 50-fold selectivity over VEGFR-2 and VEGFR-1 in cellular assays, respectively.
    EVT801 potently inhibits VEGFR-3 autophosphorylation in various mammalian species, with an IC50 in cellular assays ranging from 151 nM for the mouse receptor to 32 nM for the monkey protein.
    EVT801 undergoes O-demethylation in the cell, giving rise to the active metabolite SAR401849, which is as potent and selective as EVT801.
    EVT801 strongly inhibited VEGF-C–induced ERK1/2 phosphorylation with an IC50 of 13 nM in hLMVECs.
    EVT801 inhibited the induction of hLMVEC proliferation in a dose-dependent manner with an IC50 of 15 nmol/L for VEGF-C, 8 nmol/L for VEGF-D, and 155 nmol/L for VEGF-A, and a maximum inhibition of 74%, 100%, and 65%, respectively.
    EVT801 reduced ERK phosphorylation induced by VEGF-C and VEGF-D better than pazopanib in NCI-H1703 cells.
    EVT801(30 mg/kg twice per day, oral) showed a significant inhibition of tumor growth in NCI-H1703 tumor xenografts, blocked hypoxia-driven immunosuppression and enhances ICT efficacy.

    物理化学性质&存储条件

    分子量 367.41
    分子式 C19H21N5O3
    外观性状 Solid
    CAS No.
    储存条件
    固体粉末
    -20°C 12 个月; 4°C 6 个月
    配置液
    -80°C 6 个月; -20°C 6 个月
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    2-amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-3-(1H-imidazol-2-yl)-1,8-naphthyridin-4(1H)-one

    参考文献

    1. Michael R Paillasse, et al. Cancer Res Commun. 2022 Nov 29;2(11):1504-1519.

    备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    联系我们 sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    询单

    • *产品名称:
    • *姓名:
    • *邮箱:
    • *公司名称:
    • *询单数量:
    • *国籍:
    • 询单信息: